New negative trials on saw palmetto
© Eric Yarnell, ND, Oct 2011 Two of the largest double-blind clinical trials on Serenoa repens (saw palmetto) extracts for treatment of symptoms of benign prostatic hyperplasia (BPH) have both shown negative results (Barry, et al. 2011; Bent, et al. 2006).